Developer docs
API playgroundTry for free, no card

Search company profiles

GT Molecular

Full company profile

uuid000c86c

Namestring
GT Molecular
Legal namestring
GT Molecular, Inc.
Websiteurl
gtmolecular.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

GT Molecular is a Fort Collins, Colorado-based molecular diagnostics company, founded around 2018, that designs and commercializes ultra-sensitive digital PCR (dPCR), quantitative PCR (RT-qPCR), and next-generation sequencing (NGS) assay kits along with fee-for-service laboratory testing. Its core technology is the proprietary GT-Plex™ multiplexed PCR chemistry, described as patented or patent-pending, which the company markets as capable of detecting as few as 1–3 nucleic acid fragments per reaction. The company serves a diverse customer base that includes municipal and public-health wastewater surveillance programs, academic and clinical research laboratories, pharmaceutical and biotechnology companies, and forensic laboratories; it reaches these customers through a combination of direct sales, an e-commerce storefront, custom assay development services, and validated multi-pathogen assay panels delivered under federal contracts.

The company has built its commercial footprint primarily in wastewater-based pathogen surveillance, where it holds multi-year contracts with the CDC's National Wastewater Surveillance System covering dozens of assays, and has extended its product line into adjacent verticals including oncology research (EGFR and KRAS mutation panels), PFAS testing, arbovirus detection, and microbial-influenced-corrosion assays. A defining element of its go-to-market is platform-agnostic compatibility: GT Molecular offers kits validated on the four leading commercial dPCR platforms — Bio-Rad (QX200/QX600), QIAGEN (QIAcuity), Roche (Digital LightCycler), and Applied Biosystems/Thermo Fisher (QuantStudio Absolute Q) — enabling procurement by laboratories already invested in any major system. Revenue mechanics span federal contract awards (multi-year CDC task orders), catalog and custom kit sales, and contract laboratory testing services; the company is privately held with a headcount in the 11–50 range, and no public revenue or funding totals are disclosed in the available material.

Short descriptiontext

GT Molecular is a Fort Collins, Colorado-based molecular diagnostics company developing ultra-sensitive digital PCR, qPCR, and NGS assay kits and testing services for wastewater surveillance, oncology research, and pathogen detection, serving municipalities, academic labs, pharma, and forensic labs globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersFort Collins, United States
HQ citystring
Fort Collins
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics kits, wastewater surveillance testing, digital PCR assays, cancer genotyping panels, pathogen detection assays
Industry5 codes
PRIMARYHLAJABAI
Wastewater & Environmental Pathogen Surveillance
Healthcare & Life Sciences/Public Health, Government & Regulators/Disease Surveillance, Epidemiology & Outbreak Response
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
NAICS code4 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Molecular Diagnostics
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1PCR Assay Kit Sales
TypeOne Time License
Description

GT Molecular sells commercial PCR assay kits (digital PCR and RT-qPCR formats) for wastewater surveillance, cancer research, and pathogen detection. Kits include primers, probes, and precisely measured positive and negative controls. Products are sold through an e-commerce storefront and are compatible with multiple instrument platforms (Bio-Rad, QIAGEN, Roche, Applied Biosystems). The company also offers custom assay development services for bespoke targets.

gtmolecular.com
2Fee-for-Service Laboratory Testing
TypeProfessional Services
Description

GT Molecular provides end-to-end wastewater testing services where customers purchase testing that includes sample collection kits, prepaid overnight return shipping, laboratory processing (extraction, dPCR/qPCR/NGS), and comprehensive data reporting. Results are delivered within 24-48 hours after sample receipt. Service covers pathogens (SARS-CoV-2, Influenza, RSV, mpox, norovirus, etc.), PFAS, opioids, and microbial source tracking.

gtmolecular.com
3Custom Assay Development
TypeProfessional Services
Description

GT Molecular offers custom dPCR and qPCR assay development services, leveraging patented molecular detection technology and standards to design assays for any target on virtually any PCR platform, providing a tailored solution for unique research or surveillance needs.

gtmolecular.com
4Custom NGS Assay Development
TypeProfessional Services
Description

Custom next-generation sequencing assay development services leveraging GT Molecular's design experience to customize, validate, and perform virtually any NGS assay.

gtmolecular.com
5Custom Mass Spectrometry Assay Development
TypeProfessional Services
Description

Custom mass spectrometry assay development services for detecting minute amounts of targets of interest with customized, validated mass spectrometry assays.

gtmolecular.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details2 tiers
1PCR assay kits are sold in standard reaction sizes (typically 200 reactions per kit) with pricing determined by product type and platform compatibility.
ModelUnit PricingBilling cadencePay-as-you-go
Notes

No list pricing is publicly available. Customers contact GT Molecular for quotes. Kits include all primers, probes, and controls required for the assay.

gtmolecular.com
2Fee-for-service wastewater testing includes sample collection kit, prepaid overnight return shipping, and comprehensive report generation.
ModelOtherBilling cadencePay-as-you-go
Notes

Service pricing is not publicly listed; customers contact GT Molecular for quotes. Services cover SARS-CoV-2, Influenza, RSV, mpox, norovirus, PFAS, opioids, measles, HMPV, pertussis, hepatitis A, C. auris, and more.

gtmolecular.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1GT-Plex™
Description

Patented and patent-pending technology for highly multiplexed digital PCR and qPCR assays providing ultrasensitive detection for cancer research and pathogen detection

gtmolecular.com
+3 more records
Core offering1 text field

GT Molecular designs, manufactures, and sells digital PCR, qPCR, and next-generation sequencing (NGS) assay kits for wastewater-based pathogen surveillance and cancer mutation detection, and operates a fee-for-service laboratory offering testing for SARS-CoV-2, influenza, RSV, H5/H5N1, mpox, measles, norovirus, opioids, PFAS, and microbial source tracking. The company also provides custom assay development across dPCR, qPCR, NGS, and mass spectrometry platforms, and offers sequencing and RNA extraction services from wastewater samples.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Detection of as few as 1-3 nucleic acid fragments in wastewater samples
+5 more records
Product overview1 text field

GT Molecular offers a portfolio of molecular diagnostic products organized into assay kits, testing services, and custom assay development. Its core product lines are built around the patented GT-Plex™ technology for multiplexed digital PCR (dPCR) and real-time qPCR assays. Assay kits are available across four major dPCR/qPCR instrument platforms: Bio-Rad QX200™/QX600™, QIAGEN QIAcuity®, Applied Biosystems QuantStudio™ Absolute Q™, and Roche Digital LightCycler®, as well as RT-PCR platforms. Key product families include: (1) Wastewater surveillance assay kits for SARS-CoV-2, influenza A/B, RSV, H5, mpox, pertussis, EV-D68, and hepatitis A; (2) Respiratory multiplex panels combining Flu/SC2/RSV/BCoV targets; (3) Cancer research panels (GT-Plex™) for ESR1, EGFR, and KRAS mutations; (4) Microbial Source Tracking (MST) panels and individual assays for human, animal, and bird fecal contamination markers; (5) The GT-Fast Prep Influenza A Library Kit for Illumina NGS; and (6) A full suite of fee-for-service wastewater testing services (SARS-CoV-2, flu, RSV, mpox, H5, measles, C. auris, norovirus, HMPV, opioids, PFAS, microbial source tracking, 16S sequencing, and custom NGS) offered from GT Molecular's national laboratory. The company also provides custom assay development services for dPCR, qPCR, NGS, and mass spectrometry. GT Molecular's testing services customers receive data within 24 to 48 hours after sample receipt, and assay kits are validated for use with extraction workflows from Promega, CERES Nanotrap, and Thermo Fisher Scientific.

Product and service46 records
1GT-Digital™ Flu;SC2;RSV;BRSV Wastewater Surveillance Panel v1.0 (Bio-Rad QX600)
CategoryWastewater Surveillance Assays
Description

Multiplex digital PCR assay kit detecting influenza, SARS-CoV-2, RSV, and BRSV in wastewater samples, validated for the Bio-Rad QX600 dPCR platform and intended for public health surveillance laboratories.

2GT-Digital™ Flu;SC2;RSV;BCoV Wastewater Surveillance Panel v1.0 (QIAcuity)
CategoryWastewater Surveillance Assays
Description

Multiplex digital PCR assay kit detecting influenza, SARS-CoV-2, RSV, and bovine coronavirus in wastewater samples, validated for the QIAGEN QIAcuity platform.

3GT-Digital™ Flu;SC2;RSV Wastewater Surveillance Panel v1.0 (QuantStudio Absolute Q)
CategoryWastewater Surveillance Assays
Description

Multiplex digital PCR assay kit for influenza, SARS-CoV-2, and RSV in wastewater, validated for the Applied Biosystems QuantStudio Absolute Q dPCR platform.

4Roche Digital LightCycler® Respiratory Panel
CategoryWastewater Surveillance Assays
Description

Digital PCR respiratory pathogen assay kit validated for the Roche Digital LightCycler instrument platform.

5GT-Plex™ ESR1 Mutation Panel
CategoryCancer Genotyping Panels
Description

Digital PCR assay panel for detecting ESR1 gene mutations in cancer research and liquid biopsy applications, used by oncology research and translational laboratories.

6GT-Plex™ EGFR Mutation Panels
CategoryCancer Genotyping Panels
Description

Digital PCR assay panels for detection of EGFR mutations in cancer research and clinical research applications, marketed to oncology research laboratories.

7GT-Plex™ KRAS Mutation Panels
CategoryCancer Genotyping Panels
Description

Digital PCR assay panels for detecting KRAS mutations in cancer research samples, targeted at oncology translational and clinical research laboratories.

8GT-Digital™ HepA ROX Add-On Wastewater Surveillance Assay v1.0 (Bio-Rad QX600)
CategoryWastewater Surveillance Assays
Description

ROX-channel digital PCR add-on assay for detecting hepatitis A in wastewater, designed to run alongside other GT-Digital assays on the Bio-Rad QX600 instrument.

9GT-Digital™ HepA Wastewater Surveillance Assay v1.0 (QIAcuity)
CategoryWastewater Surveillance Assays
Description

Digital PCR assay kit for hepatitis A detection in wastewater samples, validated for the QIAGEN QIAcuity platform.

10GT-Digital™ Bordetella pertussis Wastewater Surveillance Assay Kit v1.0 (QIAcuity)
CategoryWastewater Surveillance Assays
Description

Digital PCR assay kit for detecting Bordetella pertussis in wastewater, validated for the QIAGEN QIAcuity platform and used in public-health surveillance of whooping cough.

11GT-Digital™ Bordetella pertussis Wastewater Surveillance Assay Kit v1.0 (Bio-Rad QX200/QX600)
CategoryWastewater Surveillance Assays
Description

Digital PCR assay kit for detecting Bordetella pertussis in wastewater, validated for Bio-Rad QX200 and QX600 dPCR instruments.

12GT-Digital™ EV-D68 Wastewater Surveillance Panel v1.0 (QIAcuity)
CategoryWastewater Surveillance Assays
Description

Digital PCR assay panel for detecting enterovirus D68 in wastewater samples, validated for the QIAGEN QIAcuity platform.

13GT-Digital H5* Wastewater Surveillance Assay v1.0 (QIAcuity)
CategoryWastewater Surveillance Assays
Description

Digital PCR assay kit for detecting H5-subtype avian influenza in wastewater, validated for the QIAGEN QIAcuity platform and intended for avian-flu surveillance programs.

14GT-Digital™ Microbial Source Tracking Human;E.coli;Cow;Gull;Dog Panel v1.0 (QIAGEN QIAcuity)
CategoryMicrobial Source Tracking Assays
Description

Multiplex digital PCR microbial source tracking assay differentiating human, E. coli, cow, gull, and dog fecal contributions in water samples, validated for QIAGEN QIAcuity.

15GT-Digital™ RSV Wastewater Surveillance Assay Kit (QIAGEN QIAcuity)
CategoryWastewater Surveillance Assays
Description

Digital PCR assay kit for detecting respiratory syncytial virus (RSV) in wastewater samples, validated for the QIAGEN QIAcuity platform.

16GT-Digital™ Influenza and SARS-CoV-2 Wastewater Surveillance Multiplex Assay Kit (QIAcuity)
CategoryWastewater Surveillance Assays
Description

Multiplex digital PCR assay kit for simultaneous detection of influenza and SARS-CoV-2 in wastewater, validated for the QIAGEN QIAcuity platform.

17GT Quantitative Real-Time Flu;SC2;RSV;BCoV Wastewater Surveillance Assay v1.0
CategoryWastewater Surveillance Assays
Description

Quantitative real-time (qPCR) multiplex assay for influenza, SARS-CoV-2, RSV, and bovine coronavirus in wastewater samples.

18GT Real-Time PCR SARS-CoV-2, Flu A/B and RSV Assay Kit
CategoryWastewater Surveillance Assays
Description

Real-time PCR multiplex assay for SARS-CoV-2, influenza A/B, and RSV, applicable to clinical and wastewater surveillance workflows.

19GT Real-Time MST Inland Detection Panel v1.0
CategoryMicrobial Source Tracking Assays
Description

Real-time PCR microbial source tracking panel configured for inland water applications.

20GT Real-Time MST Beach Detection Panel v1.0
CategoryMicrobial Source Tracking Assays
Description

Real-time PCR microbial source tracking panel configured for coastal/beach water applications.

21GT-Fast Prep Influenza A Library Kit for Illumina
CategoryNGS Library Prep Kits
Description

Next-generation sequencing library preparation kit for influenza A, optimized for Illumina sequencing platforms and used in viral surveillance and wastewater sequencing workflows.

22SARS-CoV-2 + Multi-Variant Wastewater Test
CategoryWastewater Testing Services
Description

Laboratory service testing wastewater samples for SARS-CoV-2 and identifying multiple variants, provided as a turnkey fee-for-service test to public-health and surveillance clients.

23SARS-CoV-2 + Pan-Omicron Variant Panel Wastewater Testing Service
CategoryWastewater Testing Services
Description

Laboratory wastewater testing service that screens for SARS-CoV-2 and characterizes Omicron-lineage variants in submitted wastewater samples.

24SARS-CoV-2 Single Test Wastewater Testing Service
CategoryWastewater Testing Services
Description

Fee-for-service single-target wastewater test detecting SARS-CoV-2 in submitted wastewater samples.

25Influenza A/B Wastewater Testing Service
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test detecting influenza A and B in submitted wastewater samples.

26Mpox Wastewater Single Test
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test detecting mpox virus in submitted wastewater samples.

27RSV Wastewater Single Test
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test detecting RSV in submitted wastewater samples.

28Respiratory Panel Wastewater Test
CategoryWastewater Testing Services
Description

Fee-for-service wastewater multiplex test covering the respiratory pathogen panel (SARS-CoV-2, influenza, RSV, etc.) in submitted wastewater samples.

29Respiratory Panel Wastewater Test (qPCR)
CategoryWastewater Testing Services
Description

qPCR-based version of the respiratory panel wastewater test service for submitted wastewater samples.

30Measles Wastewater Testing Service
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test detecting measles virus in submitted wastewater samples.

31C. auris Wastewater Testing Service
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test detecting Candida auris in submitted wastewater samples.

32Norovirus GI;GII Wastewater Testing Service
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test detecting norovirus genogroups GI and GII in submitted wastewater samples.

33HMPV Wastewater Testing Service
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test detecting human metapneumovirus (HMPV) in submitted wastewater samples.

34Microbial Source Tracking Testing Service
CategoryWastewater Testing Services
Description

Fee-for-service laboratory test profiling microbial source tracking markers in submitted water or wastewater samples.

35Opioid Testing Service for Wastewater Sample (1-5 Targets)
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test screening for 1 to 5 opioid-related analytes in submitted wastewater samples.

36Opioid Testing Service for Wastewater Sample (6+ Targets)
CategoryWastewater Testing Services
Description

Fee-for-service wastewater test screening for 6 or more opioid-related analytes in submitted wastewater samples.

37PFAS Testing Service: EPA Method 533
CategoryEnvironmental Testing Services
Description

Fee-for-service PFAS testing in submitted samples following U.S. EPA Method 533, targeted at environmental and municipal water laboratories.

38PFAS Testing Service: EPA Method 1633A
CategoryEnvironmental Testing Services
Description

Fee-for-service PFAS testing in submitted samples following U.S. EPA Method 1633A, intended for environmental and municipal water testing programs.

39Influenza H5 Milk Testing Service
CategoryEnvironmental Testing Services
Description

Fee-for-service laboratory test detecting H5-subtype avian influenza in submitted raw-milk samples for dairy surveillance programs.

40Extracted RNA from Wastewater
CategorySample Preparation Services
Description

Fee-for-service RNA extraction from submitted wastewater samples, delivering extracted RNA suitable for downstream PCR or sequencing workflows.

4116S Sequencing of Wastewater for Microbial Community Analysis
CategorySequencing Services
Description

Fee-for-service 16S rRNA sequencing of wastewater samples for microbial community analysis, providing taxonomic profiling of wastewater microbiomes.

42SARS-CoV-2 Sequencing Service for Wastewater
CategorySequencing Services
Description

Fee-for-service SARS-CoV-2 sequencing performed on submitted wastewater samples for variant identification and surveillance.

43Flu A Sequencing Service Add-on for Wastewater
CategorySequencing Services
Description

Add-on sequencing service for influenza A from submitted wastewater samples, used in conjunction with wastewater surveillance testing.

44Custom dPCR and qPCR Assays and Standards
CategoryCustom Assay Development
Description

Custom development service for digital PCR and quantitative PCR assays and reference standards, tailored to customer-specified targets for research and surveillance applications.

45Custom NGS Assays
CategoryCustom Assay Development
Description

Custom next-generation sequencing assay development service, building targeted NGS assays against customer-specified genomic targets.

46Custom Mass Spectrometry Assays
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-05-19
Description

GT Molecular introduced four new assay kits for the Applied Biosystems™ QuantStudio™ Absolute Q™ Digital PCR System, bringing its deep experience in dPCR and ultra-sensitive patented assay kits to the Absolute Q platform. New products include ESR1 mutation panel, Flu;SC2;RSV panel, BCR-ABL Fusion Detection Panel, and NPM1 Insertion Detection Assay.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-09-12
Description

GT Molecular was awarded the CDC NWSS Multi-Pathogen Assay Development Optimization, Validation, and Support contract. This work builds on previously successful CDC contracts and incorporates emerging public health threat targets from viral, bacterial, parasitic, fungal, AMR, infectious disease source tracking, and disease vector categories. The project spans up to five years (12-month base + four 12-month options) with contract value up to approximately $1.7 million. GT Molecular will develop up to 30 multi-pathogen dPCR assays for validation testing at the CDC and up to five public health partner laboratories.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-09-19
Description

GT Molecular entered into an agreement with Roche to provide a highly multiplexed respiratory panel for wastewater surveillance on the Roche Digital LightCycler® System. This digital PCR assay kit co-quantifies respiratory pathogens SARS-CoV-2, influenza A, influenza B, and RSV. The partnership enables GT Molecular to offer its assays on a fourth major platform alongside Bio-Rad, QIAGEN, and Applied Biosystems.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-06-14
Description

CDC's National Wastewater Surveillance System (NWSS) is collaborating with GT Molecular to create digital PCR assays and multiplex dPCR panels for national wastewater surveillance. The goal is to make assays available as methods and kits to public health lab partners. Targets include gastrointestinal, respiratory, and antimicrobial resistant pathogens through approximately 24 digital PCR wastewater surveillance targets. GT Molecular was previously awarded a 2023 contract (~$1.7M over 5 years) for developing 28 assays on Bio-Rad QX and Qiagen QIAcuity instruments, and in September 2024 was awarded a further multi-pathogen assay development contract.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-11-20
Description

Bio-Rad and GT Molecular announced a joint whitepaper on hMPXV (human monkeypox) surveillance and testing for wastewater-based epidemiology. GT Molecular's ddPCR™ PCR kits for WBE were demonstrated as capable and effective tools for SARS-CoV-2 outbreak monitoring and mpox detection. GT Molecular develops multiplexed assays for Bio-Rad's QX200™ and QX600™ Droplet Digital™ PCR Systems, including respiratory panels, H5 avian flu, pertussis, hepatitis A, microbial source tracking panels, and oncology panels.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-08-10
Description

GT Molecular collaborated with QIAGEN to offer a complete SARS-CoV-2 wastewater detection solution based on the QIAcuity Digital PCR technology. GT Molecular's digital SARS-CoV-2 Wastewater Surveillance Assay was developed to comply with CDC guidelines for the US National Wastewater Surveillance System (NWSS). The workflow leverages QIAGEN's sample-preparation expertise and the QIAcuity instrument platform. GT Molecular has since expanded its assay catalog for the QIAcuity platform, including multiplex respiratory panels, H5 avian flu assays, EV-D68, pertussis, hepatitis A, and microbial source tracking panels.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

QIAGEN manufactures the QIAcuity Digital PCR System that GT Molecular validates assays against and has a co-development partnership with. Comparable because QIAGEN is both an instrument partner and a competitor offering its own sample-to-result molecular diagnostic workflows including wastewater surveillance assays.

TypeDirect peer
Description

Streck provides molecular diagnostics QC, sample collection/stabilization products, and molecular testing services including wastewater surveillance. Comparable as a smaller specialty competitor serving public health and clinical labs with both consumables and testing services.

TypeBroad incumbent
Description

Eurofins operates one of the largest global networks of clinical and environmental testing laboratories, including PFAS, pathogen, and wastewater testing services. Comparable as a broad incumbent offering outsourced laboratory services across many of the same analyte categories as GT Molecular's testing services.

TypeBroad incumbent
Description

Roche Diagnostics manufactures the Digital LightCycler dPCR system for which GT Molecular developed a respiratory wastewater panel under commercial agreement. Comparable as a large diagnostics incumbent that is simultaneously a platform partner and a competitor in molecular diagnostics broadly.

TypeDirect peer
Description

Biobot Analytics is a leading wastewater-based epidemiology company providing SARS-CoV-2, influenza, RSV, and opioid surveillance services to municipalities across the US. Comparable as the most direct competitor in wastewater pathogen surveillance services, with overlapping customers (municipalities, public health departments) and similar fee-for-service testing model.

TypeBroad incumbent
Description

Bio-Rad manufactures the QX200/QX600 Droplet Digital PCR systems on which GT Molecular's assays run, and also develops its own ddPCR oncology and infectious disease assays. Comparable because Bio-Rad is both a platform partner and a direct assay competitor in the same dPCR-based molecular diagnostics space.

TypeBroad incumbent
Description

IDEXX provides water microbiology testing products and services for municipal water utilities, including microbial source tracking and waterborne pathogen detection. Comparable because it overlaps with GT Molecular's microbial source tracking and water-quality testing segments serving utilities and municipalities.

TypeDirect peer
Description

Ceres Nanosciences develops Nanotrap particle-based sample concentration workflows for wastewater pathogen detection, which GT Molecular integrates with its dPCR assays. Comparable because both companies serve the wastewater surveillance workflow with complementary technologies, and both target public health laboratories.

TypeDirect peer
Description

LuminUltra provides microbial monitoring and wastewater surveillance testing services and qPCR-based kits for water utilities and public health agencies. Comparable as a direct competitor offering end-to-end wastewater surveillance solutions, with overlapping technology (qPCR) and customer base (water utilities, municipalities).

TypeBroad incumbent
Description

Thermo Fisher manufactures the QuantStudio Absolute Q Digital PCR System for which GT Molecular launched four new assay kits in May 2025, plus the MagMAX Wastewater Ultra extraction kit. Comparable as a broad life sciences incumbent that is both a platform/extraction partner and a competitor across molecular diagnostics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GT Molecular

Molecular Diagnosticsgtmolecular.com

GT Molecular is a Fort Collins, Colorado-based molecular diagnostics company developing ultra-sensitive digital PCR, qPCR, and NGS assay kits and testing services for wastewater surveillance, oncology research, and pathogen detection, serving municipalities, academic labs, pharma, and forensic labs globally.

What GT Molecular does

GT Molecular is a Fort Collins, Colorado-based molecular diagnostics company, founded around 2018, that designs and commercializes ultra-sensitive digital PCR (dPCR), quantitative PCR (RT-qPCR), and next-generation sequencing (NGS) assay kits along with fee-for-service laboratory testing. Its core technology is the proprietary GT-Plex™ multiplexed PCR chemistry, described as patented or patent-pending, which the company markets as capable of detecting as few as 1–3 nucleic acid fragments per reaction. The company serves a diverse customer base that includes municipal and public-health wastewater surveillance programs, academic and clinical research laboratories, pharmaceutical and biotechnology companies, and forensic laboratories; it reaches these customers through a combination of direct sales, an e-commerce storefront, custom assay development services, and validated multi-pathogen assay panels delivered under federal contracts.

The company has built its commercial footprint primarily in wastewater-based pathogen surveillance, where it holds multi-year contracts with the CDC's National Wastewater Surveillance System covering dozens of assays, and has extended its product line into adjacent verticals including oncology research (EGFR and KRAS mutation panels), PFAS testing, arbovirus detection, and microbial-influenced-corrosion assays. A defining element of its go-to-market is platform-agnostic compatibility: GT Molecular offers kits validated on the four leading commercial dPCR platforms — Bio-Rad (QX200/QX600), QIAGEN (QIAcuity), Roche (Digital LightCycler), and Applied Biosystems/Thermo Fisher (QuantStudio Absolute Q) — enabling procurement by laboratories already invested in any major system. Revenue mechanics span federal contract awards (multi-year CDC task orders), catalog and custom kit sales, and contract laboratory testing services; the company is privately held with a headcount in the 11–50 range, and no public revenue or funding totals are disclosed in the available material.

GT Molecular firmographics

Firmographics
Name
GT Molecular
Legal name
GT Molecular, Inc.
Website
https://gtmolecular.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
GT Molecular is a Fort Collins, Colorado-based molecular diagnostics company developing ultra-sensitive digital PCR, qPCR, and NGS assay kits and testing services for wastewater surveillance, oncology research, and pathogen detection, serving municipalities, academic labs, pharma, and forensic labs globally.
Ownership category
akta.pro rank

GT Molecular industry classification

Industry
Product category
Molecular Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAJABAI
Wastewater & Environmental Pathogen Surveillance
Healthcare & Life Sciences/Public Health, Government & Regulators/Disease Surveillance, Epidemiology & Outbreak Response
SECONDARYHLAAALAL
Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms

Keywords

  • Molecular diagnostics kits
  • Wastewater surveillance testing
  • Digital PCR assays
  • Cancer genotyping panels
  • Pathogen detection assays

Where GT Molecular is headquartered

Location

Headquarters

HQ city
Fort Collins
HQ country
United States
HQ region
North America

Offices1 record

Markets served

GT Molecular business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. PCR Assay Kit Sales: GT Molecular sells commercial PCR assay kits (digital PCR and RT-qPCR formats) for wastewater surveillance, cancer research, and pathogen detection. Kits include primers, probes, and precisely measured positive and negative controls. Products are sold through an e-commerce storefront and are compatible with multiple instrument platforms (Bio-Rad, QIAGEN, Roche, Applied Biosystems). The company also offers custom assay development services for bespoke targets.
  2. Fee-for-Service Laboratory Testing: GT Molecular provides end-to-end wastewater testing services where customers purchase testing that includes sample collection kits, prepaid overnight return shipping, laboratory processing (extraction, dPCR/qPCR/NGS), and comprehensive data reporting. Results are delivered within 24-48 hours after sample receipt. Service covers pathogens (SARS-CoV-2, Influenza, RSV, mpox, norovirus, etc.), PFAS, opioids, and microbial source tracking.
  3. Custom Assay Development: GT Molecular offers custom dPCR and qPCR assay development services, leveraging patented molecular detection technology and standards to design assays for any target on virtually any PCR platform, providing a tailored solution for unique research or surveillance needs.
  4. Custom NGS Assay Development: Custom next-generation sequencing assay development services leveraging GT Molecular's design experience to customize, validate, and perform virtually any NGS assay.
  5. Custom Mass Spectrometry Assay Development: Custom mass spectrometry assay development services for detecting minute amounts of targets of interest with customized, validated mass spectrometry assays.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPCR assay kits are sold in standard reaction sizes (typically 200 reactions per kit) with pricing determined by product type and platform compatibility.
OtherPay-as-you-goFee-for-service wastewater testing includes sample collection kit, prepaid overnight return shipping, and comprehensive report generation.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

GT Molecular product offering

Product offering

Core offering

GT Molecular designs, manufactures, and sells digital PCR, qPCR, and next-generation sequencing (NGS) assay kits for wastewater-based pathogen surveillance and cancer mutation detection, and operates a fee-for-service laboratory offering testing for SARS-CoV-2, influenza, RSV, H5/H5N1, mpox, measles, norovirus, opioids, PFAS, and microbial source tracking. The company also provides custom assay development across dPCR, qPCR, NGS, and mass spectrometry platforms, and offers sequencing and RNA extraction services from wastewater samples.

Product overview

GT Molecular offers a portfolio of molecular diagnostic products organized into assay kits, testing services, and custom assay development. Its core product lines are built around the patented GT-Plex™ technology for multiplexed digital PCR (dPCR) and real-time qPCR assays. Assay kits are available across four major dPCR/qPCR instrument platforms: Bio-Rad QX200™/QX600™, QIAGEN QIAcuity®, Applied Biosystems QuantStudio™ Absolute Q™, and Roche Digital LightCycler®, as well as RT-PCR platforms. Key product families include: (1) Wastewater surveillance assay kits for SARS-CoV-2, influenza A/B, RSV, H5, mpox, pertussis, EV-D68, and hepatitis A; (2) Respiratory multiplex panels combining Flu/SC2/RSV/BCoV targets; (3) Cancer research panels (GT-Plex™) for ESR1, EGFR, and KRAS mutations; (4) Microbial Source Tracking (MST) panels and individual assays for human, animal, and bird fecal contamination markers; (5) The GT-Fast Prep Influenza A Library Kit for Illumina NGS; and (6) A full suite of fee-for-service wastewater testing services (SARS-CoV-2, flu, RSV, mpox, H5, measles, C. auris, norovirus, HMPV, opioids, PFAS, microbial source tracking, 16S sequencing, and custom NGS) offered from GT Molecular's national laboratory. The company also provides custom assay development services for dPCR, qPCR, NGS, and mass spectrometry. GT Molecular's testing services customers receive data within 24 to 48 hours after sample receipt, and assay kits are validated for use with extraction workflows from Promega, CERES Nanotrap, and Thermo Fisher Scientific.

Differentiator

Problem solved

Functional benefit

Brands

  • GT-Plex™: Patented and patent-pending technology for highly multiplexed digital PCR and qPCR assays providing ultrasensitive detection for cancer research and pathogen detection
  • GT-Digital™
  • GT-Fast Prep
  • GT Real-Time

Products and services

  • GT-Digital™ Flu;SC2;RSV;BRSV Wastewater Surveillance Panel v1.0 (Bio-Rad QX600) Multiplex digital PCR assay kit detecting influenza, SARS-CoV-2, RSV, and BRSV in wastewater samples, validated for the Bio-Rad QX600 dPCR platform and intended for public health surveillance laboratories.
  • GT-Digital™ Flu;SC2;RSV;BCoV Wastewater Surveillance Panel v1.0 (QIAcuity) Multiplex digital PCR assay kit detecting influenza, SARS-CoV-2, RSV, and bovine coronavirus in wastewater samples, validated for the QIAGEN QIAcuity platform.
  • GT-Digital™ Flu;SC2;RSV Wastewater Surveillance Panel v1.0 (QuantStudio Absolute Q) Multiplex digital PCR assay kit for influenza, SARS-CoV-2, and RSV in wastewater, validated for the Applied Biosystems QuantStudio Absolute Q dPCR platform.
  • Roche Digital LightCycler® Respiratory Panel Digital PCR respiratory pathogen assay kit validated for the Roche Digital LightCycler instrument platform.
  • GT-Plex™ ESR1 Mutation Panel Digital PCR assay panel for detecting ESR1 gene mutations in cancer research and liquid biopsy applications, used by oncology research and translational laboratories.
  • GT-Plex™ EGFR Mutation Panels Digital PCR assay panels for detection of EGFR mutations in cancer research and clinical research applications, marketed to oncology research laboratories.
  • GT-Plex™ KRAS Mutation Panels Digital PCR assay panels for detecting KRAS mutations in cancer research samples, targeted at oncology translational and clinical research laboratories.
  • GT-Digital™ HepA ROX Add-On Wastewater Surveillance Assay v1.0 (Bio-Rad QX600) ROX-channel digital PCR add-on assay for detecting hepatitis A in wastewater, designed to run alongside other GT-Digital assays on the Bio-Rad QX600 instrument.
  • GT-Digital™ HepA Wastewater Surveillance Assay v1.0 (QIAcuity) Digital PCR assay kit for hepatitis A detection in wastewater samples, validated for the QIAGEN QIAcuity platform.
  • GT-Digital™ Bordetella pertussis Wastewater Surveillance Assay Kit v1.0 (QIAcuity) Digital PCR assay kit for detecting Bordetella pertussis in wastewater, validated for the QIAGEN QIAcuity platform and used in public-health surveillance of whooping cough.
  • GT-Digital™ Bordetella pertussis Wastewater Surveillance Assay Kit v1.0 (Bio-Rad QX200/QX600) Digital PCR assay kit for detecting Bordetella pertussis in wastewater, validated for Bio-Rad QX200 and QX600 dPCR instruments.
  • GT-Digital™ EV-D68 Wastewater Surveillance Panel v1.0 (QIAcuity) Digital PCR assay panel for detecting enterovirus D68 in wastewater samples, validated for the QIAGEN QIAcuity platform.
  • GT-Digital H5* Wastewater Surveillance Assay v1.0 (QIAcuity) Digital PCR assay kit for detecting H5-subtype avian influenza in wastewater, validated for the QIAGEN QIAcuity platform and intended for avian-flu surveillance programs.
  • GT-Digital™ Microbial Source Tracking Human;E.coli;Cow;Gull;Dog Panel v1.0 (QIAGEN QIAcuity) Multiplex digital PCR microbial source tracking assay differentiating human, E. coli, cow, gull, and dog fecal contributions in water samples, validated for QIAGEN QIAcuity.
  • GT-Digital™ RSV Wastewater Surveillance Assay Kit (QIAGEN QIAcuity) Digital PCR assay kit for detecting respiratory syncytial virus (RSV) in wastewater samples, validated for the QIAGEN QIAcuity platform.
  • GT-Digital™ Influenza and SARS-CoV-2 Wastewater Surveillance Multiplex Assay Kit (QIAcuity) Multiplex digital PCR assay kit for simultaneous detection of influenza and SARS-CoV-2 in wastewater, validated for the QIAGEN QIAcuity platform.
  • GT Quantitative Real-Time Flu;SC2;RSV;BCoV Wastewater Surveillance Assay v1.0 Quantitative real-time (qPCR) multiplex assay for influenza, SARS-CoV-2, RSV, and bovine coronavirus in wastewater samples.
  • GT Real-Time PCR SARS-CoV-2, Flu A/B and RSV Assay Kit Real-time PCR multiplex assay for SARS-CoV-2, influenza A/B, and RSV, applicable to clinical and wastewater surveillance workflows.
  • GT Real-Time MST Inland Detection Panel v1.0 Real-time PCR microbial source tracking panel configured for inland water applications.
  • GT Real-Time MST Beach Detection Panel v1.0 Real-time PCR microbial source tracking panel configured for coastal/beach water applications.
  • GT-Fast Prep Influenza A Library Kit for Illumina Next-generation sequencing library preparation kit for influenza A, optimized for Illumina sequencing platforms and used in viral surveillance and wastewater sequencing workflows.
  • SARS-CoV-2 + Multi-Variant Wastewater Test Laboratory service testing wastewater samples for SARS-CoV-2 and identifying multiple variants, provided as a turnkey fee-for-service test to public-health and surveillance clients.
  • SARS-CoV-2 + Pan-Omicron Variant Panel Wastewater Testing Service Laboratory wastewater testing service that screens for SARS-CoV-2 and characterizes Omicron-lineage variants in submitted wastewater samples.
  • SARS-CoV-2 Single Test Wastewater Testing Service Fee-for-service single-target wastewater test detecting SARS-CoV-2 in submitted wastewater samples.
  • Influenza A/B Wastewater Testing Service Fee-for-service wastewater test detecting influenza A and B in submitted wastewater samples.
  • Mpox Wastewater Single Test Fee-for-service wastewater test detecting mpox virus in submitted wastewater samples.
  • RSV Wastewater Single Test Fee-for-service wastewater test detecting RSV in submitted wastewater samples.
  • Respiratory Panel Wastewater Test Fee-for-service wastewater multiplex test covering the respiratory pathogen panel (SARS-CoV-2, influenza, RSV, etc.) in submitted wastewater samples.
  • Respiratory Panel Wastewater Test (qPCR) qPCR-based version of the respiratory panel wastewater test service for submitted wastewater samples.
  • Measles Wastewater Testing Service Fee-for-service wastewater test detecting measles virus in submitted wastewater samples.
  • C. auris Wastewater Testing Service Fee-for-service wastewater test detecting Candida auris in submitted wastewater samples.
  • Norovirus GI;GII Wastewater Testing Service Fee-for-service wastewater test detecting norovirus genogroups GI and GII in submitted wastewater samples.
  • HMPV Wastewater Testing Service Fee-for-service wastewater test detecting human metapneumovirus (HMPV) in submitted wastewater samples.
  • Microbial Source Tracking Testing Service Fee-for-service laboratory test profiling microbial source tracking markers in submitted water or wastewater samples.
  • Opioid Testing Service for Wastewater Sample (1-5 Targets) Fee-for-service wastewater test screening for 1 to 5 opioid-related analytes in submitted wastewater samples.
  • Opioid Testing Service for Wastewater Sample (6+ Targets) Fee-for-service wastewater test screening for 6 or more opioid-related analytes in submitted wastewater samples.
  • PFAS Testing Service: EPA Method 533 Fee-for-service PFAS testing in submitted samples following U.S. EPA Method 533, targeted at environmental and municipal water laboratories.
  • PFAS Testing Service: EPA Method 1633A Fee-for-service PFAS testing in submitted samples following U.S. EPA Method 1633A, intended for environmental and municipal water testing programs.
  • Influenza H5 Milk Testing Service Fee-for-service laboratory test detecting H5-subtype avian influenza in submitted raw-milk samples for dairy surveillance programs.
  • Extracted RNA from Wastewater Fee-for-service RNA extraction from submitted wastewater samples, delivering extracted RNA suitable for downstream PCR or sequencing workflows.
  • 16S Sequencing of Wastewater for Microbial Community Analysis Fee-for-service 16S rRNA sequencing of wastewater samples for microbial community analysis, providing taxonomic profiling of wastewater microbiomes.
  • SARS-CoV-2 Sequencing Service for Wastewater Fee-for-service SARS-CoV-2 sequencing performed on submitted wastewater samples for variant identification and surveillance.
  • Flu A Sequencing Service Add-on for Wastewater Add-on sequencing service for influenza A from submitted wastewater samples, used in conjunction with wastewater surveillance testing.
  • Custom dPCR and qPCR Assays and Standards Custom development service for digital PCR and quantitative PCR assays and reference standards, tailored to customer-specified targets for research and surveillance applications.
  • Custom NGS Assays Custom next-generation sequencing assay development service, building targeted NGS assays against customer-specified genomic targets.
  • Custom Mass Spectrometry Assays

Quantifiable outcome

  • Detection of as few as 1-3 nucleic acid fragments in wastewater samples
  • +5 more outcomes

Companies that use GT Molecular

Customer profile

Named customers1 record

Segments7 records

Ideal customer profiles4 records

GT Molecular technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

Feature9 records

GT Molecular partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and flagship.

  • Applied Biosystems (Thermo Fisher Scientific)coreTechnology or Integration · 19 May 2025GT Molecular introduced four new assay kits for the Applied Biosystems™ QuantStudio™ Absolute Q™ Digital PCR System, bringing its deep experience in dPCR and ultra-sensitive patented assay kits to the Absolute Q platform. New products include ESR1 mutation panel, Flu;SC2;RSV panel, BCR-ABL Fusion Detection Panel, and NPM1 Insertion Detection Assay.
  • Centers for Disease Control and Prevention (CDC) — NWSS Multi-Pathogen ContractflagshipStrategic or Co-development Partner · 12 September 2024GT Molecular was awarded the CDC NWSS Multi-Pathogen Assay Development Optimization, Validation, and Support contract. This work builds on previously successful CDC contracts and incorporates emerging public health threat targets from viral, bacterial, parasitic, fungal, AMR, infectious disease source tracking, and disease vector categories. The project spans up to five years (12-month base + four 12-month options) with contract value up to approximately $1.7 million. GT Molecular will develop up to 30 multi-pathogen dPCR assays for validation testing at the CDC and up to five public health partner laboratories.
  • Roche (Diagnostics)coreTechnology or Integration · 19 September 2023GT Molecular entered into an agreement with Roche to provide a highly multiplexed respiratory panel for wastewater surveillance on the Roche Digital LightCycler® System. This digital PCR assay kit co-quantifies respiratory pathogens SARS-CoV-2, influenza A, influenza B, and RSV. The partnership enables GT Molecular to offer its assays on a fourth major platform alongside Bio-Rad, QIAGEN, and Applied Biosystems.
  • Centers for Disease Control and Prevention (CDC)flagshipStrategic or Co-development Partner · 14 June 2023CDC's National Wastewater Surveillance System (NWSS) is collaborating with GT Molecular to create digital PCR assays and multiplex dPCR panels for national wastewater surveillance. The goal is to make assays available as methods and kits to public health lab partners. Targets include gastrointestinal, respiratory, and antimicrobial resistant pathogens through approximately 24 digital PCR wastewater surveillance targets. GT Molecular was previously awarded a 2023 contract (~$1.7M over 5 years) for developing 28 assays on Bio-Rad QX and Qiagen QIAcuity instruments, and in September 2024 was awarded a further multi-pathogen assay development contract.
  • Bio-Rad LaboratoriescoreTechnology or Integration · 20 November 2022Bio-Rad and GT Molecular announced a joint whitepaper on hMPXV (human monkeypox) surveillance and testing for wastewater-based epidemiology. GT Molecular's ddPCR™ PCR kits for WBE were demonstrated as capable and effective tools for SARS-CoV-2 outbreak monitoring and mpox detection. GT Molecular develops multiplexed assays for Bio-Rad's QX200™ and QX600™ Droplet Digital™ PCR Systems, including respiratory panels, H5 avian flu, pertussis, hepatitis A, microbial source tracking panels, and oncology panels.
  • QIAGENcoreTechnology or Integration · 10 August 2021GT Molecular collaborated with QIAGEN to offer a complete SARS-CoV-2 wastewater detection solution based on the QIAcuity Digital PCR technology. GT Molecular's digital SARS-CoV-2 Wastewater Surveillance Assay was developed to comply with CDC guidelines for the US National Wastewater Surveillance System (NWSS). The workflow leverages QIAGEN's sample-preparation expertise and the QIAcuity instrument platform. GT Molecular has since expanded its assay catalog for the QIAcuity platform, including multiplex respiratory panels, H5 avian flu assays, EV-D68, pertussis, hepatitis A, and microbial source tracking panels.

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

GT Molecular competitors and assessment

Company assessment

Broad incumbents

  • QIAGEN: QIAGEN manufactures the QIAcuity Digital PCR System that GT Molecular validates assays against and has a co-development partnership with. Comparable because QIAGEN is both an instrument partner and a competitor offering its own sample-to-result molecular diagnostic workflows including wastewater surveillance assays.
  • Eurofins Scientific: Eurofins operates one of the largest global networks of clinical and environmental testing laboratories, including PFAS, pathogen, and wastewater testing services. Comparable as a broad incumbent offering outsourced laboratory services across many of the same analyte categories as GT Molecular's testing services.
  • Roche Diagnostics: Roche Diagnostics manufactures the Digital LightCycler dPCR system for which GT Molecular developed a respiratory wastewater panel under commercial agreement. Comparable as a large diagnostics incumbent that is simultaneously a platform partner and a competitor in molecular diagnostics broadly.
  • Bio-Rad Laboratories: Bio-Rad manufactures the QX200/QX600 Droplet Digital PCR systems on which GT Molecular's assays run, and also develops its own ddPCR oncology and infectious disease assays. Comparable because Bio-Rad is both a platform partner and a direct assay competitor in the same dPCR-based molecular diagnostics space.
  • IDEXX Laboratories: IDEXX provides water microbiology testing products and services for municipal water utilities, including microbial source tracking and waterborne pathogen detection. Comparable because it overlaps with GT Molecular's microbial source tracking and water-quality testing segments serving utilities and municipalities.
  • Thermo Fisher Scientific: Thermo Fisher manufactures the QuantStudio Absolute Q Digital PCR System for which GT Molecular launched four new assay kits in May 2025, plus the MagMAX Wastewater Ultra extraction kit. Comparable as a broad life sciences incumbent that is both a platform/extraction partner and a competitor across molecular diagnostics.

Direct peers

  • Streck: Streck provides molecular diagnostics QC, sample collection/stabilization products, and molecular testing services including wastewater surveillance. Comparable as a smaller specialty competitor serving public health and clinical labs with both consumables and testing services.
  • Biobot Analytics: Biobot Analytics is a leading wastewater-based epidemiology company providing SARS-CoV-2, influenza, RSV, and opioid surveillance services to municipalities across the US. Comparable as the most direct competitor in wastewater pathogen surveillance services, with overlapping customers (municipalities, public health departments) and similar fee-for-service testing model.
  • Ceres Nanosciences: Ceres Nanosciences develops Nanotrap particle-based sample concentration workflows for wastewater pathogen detection, which GT Molecular integrates with its dPCR assays. Comparable because both companies serve the wastewater surveillance workflow with complementary technologies, and both target public health laboratories.
  • LuminUltra: LuminUltra provides microbial monitoring and wastewater surveillance testing services and qPCR-based kits for water utilities and public health agencies. Comparable as a direct competitor offering end-to-end wastewater surveillance solutions, with overlapping technology (qPCR) and customer base (water utilities, municipalities).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

GT Molecular social profiles

Digital presence

GT Molecular financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GT Molecular leadership team

Management profile

Number of profiles

GT Molecular funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GT Molecular M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GT Molecular

What does GT Molecular do?

GT Molecular designs, manufactures, and sells digital PCR, qPCR, and next-generation sequencing (NGS) assay kits for wastewater-based pathogen surveillance and cancer mutation detection, and operates a fee-for-service laboratory offering testing for SARS-CoV-2, influenza, RSV, H5/H5N1, mpox, measles, norovirus, opioids, PFAS, and microbial source tracking. The company also provides custom assay development across dPCR, qPCR, NGS, and mass spectrometry platforms, and offers sequencing and RNA extraction services from wastewater samples.

Is GT Molecular a public or private company?

GT Molecular is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was GT Molecular founded?

GT Molecular was founded in 2018. It employs 11 to 50 people.

Where is GT Molecular based?

GT Molecular is headquartered in Fort Collins, United States, in the North America region.

How does GT Molecular make money?

Five revenue lines are on record. PCR Assay Kit Sales are the primary driver. The others are fee-for-Service Laboratory Testing, custom Assay Development, custom NGS Assay Development and custom Mass Spectrometry Assay Development.

Who are GT Molecular's main competitors?

Broad incumbents on record are QIAGEN, Eurofins Scientific, Roche Diagnostics, Bio-Rad Laboratories, IDEXX Laboratories and Thermo Fisher Scientific. Direct peers are Streck, Biobot Analytics, Ceres Nanosciences and LuminUltra.

Does GT Molecular have an API?

No public API is recorded for GT Molecular.

What industry is GT Molecular in?

GT Molecular's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAJABAI, Wastewater & Environmental Pathogen Surveillance, with a secondary code of HLAAALAL, Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGT Molecular Announces Entry into the Cancer Molecular Assay Market with two PCR Multiplex Panels for the EGFR and KRAS GenesGT Molecular announced its entry into the cancer molecular assay market with the launch of two Research Use Only (RUO) PCR multiplex panels targeting the EGFR and KRAS G12C genes, both commonly found in human cancers. The GT-Plex EGFR Panel can detect over 30 actionable mutations spanning exons 18 through 21, while the KRAS G12C Duplex Panel identifies the G12C mutation relative to wildtype. Both kits are designed and optimized for Bio-Rad's QX200 and QX600 Droplet Digital PCR Systems, offering high sensitivity of at least 0.01% variant allele frequency with same-day results.PR NewswireGT Molecular Releases Respiratory Panels and Poliovirus Typing Assays for Leading PCR PlatformsGT Molecular, a Fort Collins-based PCR assay and wastewater testing company, announced on December 20, 2022 the release of new Multiplexed Respiratory Panels and Poliovirus Typing Assays for major digital PCR and RT-PCR platforms including Bio-Rad, QIAGEN, and Thermo Fisher Scientific. The respiratory panels detect SARS-CoV-2, Influenza A/B, and RSV with Omicron-optimized targets, while the polio assays identify Types 1, 2, and 3. The company is positioning these products for clinical research and wastewater-based epidemiology applications, with offerings that include kit sales and national testing services.PR NewswireGT Molecular Announces Highly Sensitive Digital PCR and Real Time qPCR Kits for hMPXV (Human Monkeypox)GT Molecular announced the launch of highly sensitive digital PCR and real-time qPCR kits for detecting human monkeypox virus (hMPXV) in wastewater, featuring quality control metrics including internal process control and fecal indicators. The company is also offering a national dPCR and NGS testing service for wastewater surveillance, providing sample collection kits and comprehensive reporting. GT Molecular and Bio-Rad are co-hosting a webinar on July 28, 2022, to discuss the use of droplet digital PCR approaches for quantifying and tracking monkeypox outbreaks.PR NewswireGT Molecular Ships its Patent-Pending Multiplexed RT-qPCR Test for the Omicron and Delta Coronavirus VariantsGT Molecular announced the release and shipping of patent-pending multiplexed RT-qPCR and digital PCR reagent kits designed specifically for detecting the SARS-CoV-2 Omicron (B.1.1.529), Delta, and Delta+ variants. The kits are compatible with multiple PCR platforms including Bio-Rad Touch CFX96, Thermo QuantStudio 5, Bio-Rad QX200, and Qiagen QIAcuity, and the company also offers a national wastewater-based testing service for variant monitoring. The company states it has empowered hundreds of academic, commercial, and public testing laboratories worldwide with its molecular diagnostic kits.PR NewswireGT Molecular Announces a Highly Sensitive Wastewater Testing Service for the Omicron Coronavirus VariantGT Molecular, a Fort Collins, Colorado-based PCR assay company, announced the upcoming release of wastewater-based testing services and reagent kits specifically designed to detect the SARS-CoV-2 Omicron variant (B.1.1.529). The company is offering a national wastewater epidemiology testing service that tests sewage from communities for key mutations defining the B.1.1.529 variant, along with patent-pending RT-qPCR and digital PCR reagent kits for academic, commercial, and public testing laboratories. The Omicron variant, first identified in South Africa, was designated a "variant of concern" by the WHO and contains more than 30 mutations in the spike protein, with preliminary findings suggesting higher transmission risk.BioSpaceQIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR TechnologyQIAGEN and GT Molecular launched a wastewater SARS-CoV-2 detection workflow in August, combining QIAGEN's QIAcuity digital PCR with GT Molecular's assay. The workflow delivers results in under 2.5 hours, compared to up to 6 hours with other dPCR systems, and complies with CDC guidelines for U.S. wastewater surveillance.PR NewswireGT Molecular Launches Highly Sensitive PCR Tests for the SARS-CoV-2 Delta Variant and Influenza A/BGT Molecular, a Colorado-based company specializing in wastewater testing and multiplex PCR assays, has launched and begun shipping sensitive PCR tests designed to detect and differentiate the SARS-CoV-2 Delta variant (B.1.617.2), which was first identified in India in December 2020 and has become the dominant variant in the United States. The company has expanded its offerings to include multi-variant digital PCR kits, stand-alone Delta/Epsilon kits, Influenza A/B detection kits, and fee-for-service laboratory testing services for researchers and policymakers. This launch adds to GT Molecular's growing molecular assay catalog that includes SARS-CoV-2 multi-variant tests, cancer panels, and multiplexed pathogen panels for clinical labs.PR NewswireGT Molecular Launches Highly Sensitive Multiplexed PCR Tests for the Indian Coronavirus VariantGT Molecular, a Fort Collins, Colorado-based company specializing in multiplexed PCR assays, has begun shipping PCR tests specifically designed to detect the B.1.617 coronavirus variant first identified in India. The company is offering two products: a national wastewater-based epidemiology testing service and ultrasensitive RT-PCR/dPCR reagent kits for detecting multiple variants including the Indian variant. The B.1.617 variant was upgraded to a global variant of concern by the WHO and is referred to as the "double mutant" due to its two mutations of concern.PR NewswireGT Molecular launches highly sensitive PCR-based tests for UK, South African, and Brazilian/Japanese Variants of ConcernGT Molecular, a Colorado-based molecular testing company, has launched highly sensitive PCR-based tests capable of detecting the UK, South African, and Brazilian/Japanese variants of SARS-CoV-2 in wastewater samples across the United States. The tests are offered as nationwide fee-for-service wastewater testing services and as commercial reagent kits for research labs, environmental labs, CLIA labs, and health officials. The company reports that its wastewater surveillance data has been validated by state laboratories and is being used by cities including Altamonte Springs, Florida and Burlington, Vermont to inform pandemic response decisions.PR NewswireHyper-Transmissible SARS-CoV-2 Variant Detected in United States WastewaterGT Molecular detected the hyper-transmissible SARS-CoV-2 B.1.1.7 (UK) variant in wastewater from three treatment plants in the United States, providing evidence that the variant or a similar strain is spreading domestically. The company is offering the detection test immediately as both a fee-for-service and a ready-to-use PCR kit for testing labs, enabling health officials to monitor variant presence in communities. GT Molecular plans to continue nationwide wastewater screening and share its molecular reagents with the broader wastewater-based epidemiology community.